by Frank R. Lichtenberg
No reviews yet. Be the first!
The benefits and costs of newer drugs
The expanding pharmaceutical arsenal in ...
Are increasing 5-year survival rates evi...
A comparison of NSF/census and alternati...
International R&D spillovers
The allocation of publicly-funded biomed...
Financial audit
[William Wheeler Hubbell, authorized to ...
Report of the superintending school comm...
Tax administration
U.S. Postal Service